AIxCrypto and FF AI-Robotics Announce Strategic Partnership to Explore Web3 Infrastructure for Embodied AI
AIxC and Sei Development Foundation Announce Strategic Collaboration
AIxCrypto Co-CEO Jerry Wang Shares Weekly Investor Update: $10 million FFAI Strategic Investment, 1M+ Wallets, and Sei Collaboration
AIxCrypto Inc. Surpasses 1.1 Million Registered Wallets as AIxC Hub Launches "Tenki" Interactive Game
Qualigen Therapeutics (NASDAQ:AIXC) is now covered by analysts at
Weiss Ratings. They set a "sell (e+)" rating on the stock.